Skip to Content for Our View on Pricing Menu for Our View on Pricing About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Our View on Pricing

We understand the concerns expressed about the price of cancer drugs. We are committed to engaging in a dialogue with patients, physicians and other interested parties about what it takes to try to cure cancer, our dedication to making our medicines accessible to all patients who need them, and the larger societal concerns about the cost of health care.

USA TODAY Letter to the Editor Read a letter to the editor from Chief Executive Officer Art Levinson called "Don't Overlook Cancer Research Triumphs," published in USA TODAY on July 21, 2006.

Feedback We are always interested in hearing from our website visitors. If you have feedback on our view on pricing, please take a moment to complete our .

Commitment to Access Jean

For more than 20 years, Genentech has been committed to making sure price is not a barrier to access for patients. Read about Genentech's various programs and donations.